These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38951065)

  • 21. Novel mutations in Thai patients with glanzmann thrombasthenia.
    Ittiwut R; Suchartlikitwong P; Kittikalayawong Y; Ittiwut C; Prasopsanti K; Sosothikul D; Shotelersuk V; Suphapeetiporn K
    Eur J Haematol; 2017 Dec; 99(6):520-524. PubMed ID: 28888044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel heterozygous mutation flanking the fourth calcium-binding domain of the ITGA2B gene induces severe bleeding complications: a case report and literature review.
    Xu Q; Zhou M; Xu M; Zhang L; Zhang X
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):146-150. PubMed ID: 33196509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of the ITGA2B Nonsense Mutation (c.2659C > T, p.Q887X) on Platelet Function in a Mouse Model of Glanzmann's Thrombasthenia Generated with CRISPR/Cas9 Technology].
    Yang F; Jiang M; Lin ZH; Xie ZL; Ma ZN; Yang L; Liu H; Wang ZY; Zhou L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):559-564. PubMed ID: 35395997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.
    Ali T; Gul S; Amar A; Shakoor M; Farhan S; Mohsin S; Khaliq S
    Int J Lab Hematol; 2020 Oct; 42(5):628-635. PubMed ID: 32558238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two novel ITGA2B mutations in a Glanzmann thrombasthaenia family associated with different platelet phenotypic expression.
    Daidone V; Bury L; Milan M; Galletta E; Gresele P; Casonato A
    Blood Transfus; 2017 Sep; 15(5):487-488. PubMed ID: 27416581
    [No Abstract]   [Full Text] [Related]  

  • 26. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of platelet surface glycoproteins in patients with Glanzmann thrombasthenia: Association with bleeding symptoms.
    Mutreja D; Sharma RK; Purohit A; Aggarwal M; Saxena R
    Indian J Med Res; 2017 May; 145(5):629-634. PubMed ID: 28948953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpression.
    Hu L; Du L; Zhao Y; Li W; Ouyang Q; Zhou D; Lu G; Lin G
    Stem Cell Res; 2017 Apr; 20():14-20. PubMed ID: 28232155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mutation screening and prenatal diagnosis of a pedigree with Glanzmann's thrombasthenia].
    Li W; Liu JL; Li LY; Lu GX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):251-5. PubMed ID: 21644217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An αIIb mutation in patients with Glanzmann thrombasthenia located in the N-terminus of blade 1 of the β-propeller (Asn2Asp) disrupts a calcium binding site in blade 6.
    Mansour W; Einav Y; Hauschner H; Koren A; Seligsohn U; Rosenberg N
    J Thromb Haemost; 2011 Jan; 9(1):192-200. PubMed ID: 21029361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
    Nurden AT; Pillois X; Nurden P
    Expert Rev Hematol; 2012 Oct; 5(5):487-503. PubMed ID: 23146053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type II Glanzmann thrombasthenia in a compound heterozygote for the alpha IIb gene. A novel missense mutation in exon 27.
    Jayo A; Pabón D; Lastres P; Jiménez-Yuste V; González-Manchón C
    Haematologica; 2006 Oct; 91(10):1352-9. PubMed ID: 17018384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.
    Akuta K; Kashiwagi H; Yujiri T; Nishiura N; Morikawa Y; Kato H; Honda S; Kanakura Y; Tomiyama Y
    J Thromb Haemost; 2019 Jan; 17(1):206-219. PubMed ID: 30388316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular diversity of Glanzmann thrombasthenia in southern India: new insights into mRNA splicing and structure-function correlations of alphaIIbbeta3 integrin (ITGA2B, ITGB3).
    Peretz H; Rosenberg N; Landau M; Usher S; Nelson EJ; Mor-Cohen R; French DL; Mitchell BW; Nair SC; Chandy M; Coller BS; Srivastava A; Seligsohn U
    Hum Mutat; 2006 Apr; 27(4):359-69. PubMed ID: 16463284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal cytoplasmic extensions associated with active αIIbβ3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome.
    Hauschner H; Mor-Cohen R; Messineo S; Mansour W; Seligsohn U; Savoia A; Rosenberg N
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):302-8. PubMed ID: 25806962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia.
    Chen YP; Djaffar I; Pidard D; Steiner B; Cieutat AM; Caen JP; Rosa JP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10169-73. PubMed ID: 1438206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains.
    Koker MY; Sarper N; Albayrak C; Zulfikar B; Zengin E; Saraymen B; Albayrak D; Koc B; Avcilar H; Karakükcü M; Chenet C; Bianchi F; de Brevern AG; Petermann R; Jallu V
    Platelets; 2022 May; 33(4):551-561. PubMed ID: 34275420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients.
    Rosenberg N; Dardik R; Hauschner H; Nakav S; Barel O; Luboshitz J; Yacobovich J; Tamary H; Kenet G
    Blood Cells Mol Dis; 2021 Jul; 89():102560. PubMed ID: 33711653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.
    Wang R; Shattil SJ; Ambruso DR; Newman PJ
    J Clin Invest; 1997 Nov; 100(9):2393-403. PubMed ID: 9351872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel Phe171Cys mutation in integrin alpha causes Glanzmann thrombasthenia by abrogating alphabeta complex formation.
    Rosenberg N; Landau M; Luboshitz J; Rechavi G; Seligsohn U
    J Thromb Haemost; 2004 Jul; 2(7):1167-75. PubMed ID: 15219201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.